Efficacy and Safety of Upadacitinib in Patients with Ankylosing Spondylitis with Intolerance to And/or Lack of Efficacy of Prior Biologic Therapy: A Subgroup Analysis

被引：0
|
作者：
Baraliakos, Xenofon [1 ]
Ganz, Fabiana [2 ]
Kameda, Hideto [3 ]
Walsh, Jessica [4 ]
Jain, Manish [5 ]
D'Silva, Kristin [6 ]
Wung, Peter [6 ]
Bu, Xianwei [6 ]
Stigler, Jayne [6 ]
Van der Heijde, Desiree [6 ]
机构：
[1] Rheumazentrum Ruhrgebiet Herne, Herne, Germany
[2] AbbVie Inc, Luzern, Switzerland
[3] Toho Univ, Tokyo, Japan
[4] Univ Utah, Salt Lake City, UT USA
[5] Great Lakes Clin Trials, Chicago, IL USA
[6] AbbVie Inc, N Chicago, IL USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2022年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0414
引用
收藏
页码：825 / 827
页数：3
相关论文
共 50 条
  • [21] Infliximab therapy inpatients with ankylosing spondylitis: An open label study on efficacy and safety
    Macieira, C
    Costa, M
    Ramos, F
    Sequeira, G
    Castelao, W
    de Queiroz, MV
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 404 - 404
  • [22] SAFETY AND EFFICACY OF PIROXICAM IN THE TREATMENT OF ANKYLOSING-SPONDYLITIS
    RADI, I
    MATOSO, L
    POSMANTIR, A
    PAPALEXIOU, P
    EUROPEAN JOURNAL OF RHEUMATOLOGY AND INFLAMMATION, 1978, 1 (03) : 349 - 351
  • [23] A cost efficacy analysis on anti-TNF therapy in ankylosing spondylitis
    Singh, G
    Tandon, N
    Bala, M
    VALUE IN HEALTH, 2004, 7 (06) : 663 - 664
  • [24] A cost efficacy analysis on anti-TNF therapy in ankylosing spondylitis
    Singh, G
    Tandon, N
    Bala, M
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 395 - 395
  • [25] Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis refractory to biologic therapy: 2-year clinical and radiographic results from the open-label extension of the SELECT-AXIS 2 study
    Baraliakos, Xenofon
    van der Heijde, Desiree
    Sieper, Joachim
    Inman, Robert Davies
    Kameda, Hideto
    Maksymowych, Walter Peter
    Lagunes-Galindo, Ivan
    Bu, Xianwei
    Wung, Peter
    Kato, Koji
    Shmagel, Anna
    Deodhar, Atul
    ARTHRITIS RESEARCH & THERAPY, 2024, 26 (01)
  • [26] THE EFFICACY OF PULMONARY REHABILITATION IN PATIENTS WITH ANKYLOSING SPONDYLITIS
    Sahin, N.
    Sarioglu, N.
    Gorcan, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1919 - 1919
  • [27] Efficacy and safety of mesalazine (Salofalk®) in an open study of 20 patients with ankylosing spondylitis
    van Denderen, JC
    van der Horst-Bruinsma, IE
    Bezemer, PD
    Dijkmans, BAC
    JOURNAL OF RHEUMATOLOGY, 2003, 30 (07) : 1558 - 1560
  • [28] Meta-analysis of efficacy of anti-TNF alpha therapy in ankylosing spondylitis patients
    Montilla Salas, Juan
    Munoz Gomariz, Elisa
    Collantesa, Eduardo
    REUMATOLOGIA CLINICA, 2007, 3 (05): : 204 - 212
  • [29] Infliximab in ankylosing spondylitis: A prospective observational inception cohort analysis of efficacy and safety
    Maksymowych, WP
    Jhangri, GS
    Lambert, RG
    Mallon, C
    Buenviaje, H
    Pedrycz, E
    Luongo, R
    Russell, AS
    JOURNAL OF RHEUMATOLOGY, 2002, 29 (05) : 959 - 965
  • [30] Exposure-Response Analyses for Upadacitinib Efficacy and Safety in Ankylosing Spondylitis - Analyses of the SELECT-AXIS I Study
    Ismail, Mohamed
    Nader, Ahmed
    Winzenborg, Insa
    Song, In-Ho
    Othman, Ahmed
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
12345